- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/24 - MucusGlandes des muqueusesBoursesLiquide synovialLiquide articulaireExcretaLiquide céphalorachidien
Détention brevets de la classe A61K 35/24
Brevets de cette classe: 118
Historique des publications depuis 10 ans
17
|
10
|
18
|
11
|
6
|
6
|
17
|
13
|
14
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Finch Therapeutics Holdings, LLC | 74 |
29 |
Regents of the University of Minnesota | 2701 |
8 |
Novel Biome Solutions Inc. | 6 |
4 |
Cedars-Sinai Medical Center | 1165 |
3 |
The University of North Carolina at Chapel Hill | 2053 |
3 |
Wake Forest University Health Sciences | 723 |
3 |
California Institute of Technology | 3986 |
2 |
Caelus Pharmaceuticals B.V. | 23 |
2 |
P Tech, LLC | 146 |
2 |
Sapienza Universita di Roma | 31 |
2 |
Technion Research & Development Foundation Ltd. | 1228 |
2 |
AniCell BioTech, LLC | 8 |
2 |
Foshan University | 77 |
2 |
Microbiota I - Center (magic) Limited | 10 |
2 |
The Regents of the University of California | 20087 |
1 |
Pfizer Inc. | 3375 |
1 |
Board of Regents, The University of Texas System | 5860 |
1 |
The Trustees of the University of Pennsylvania | 4342 |
1 |
University of South Florida | 1840 |
1 |
BAE Systems Australia Limited | 35 |
1 |
Autres propriétaires | 46 |